Research summary

Probiotics and Antibiotic Diarrhea

Quick answer

Two 2021 meta-analyses of randomized controlled trials in adults found that taking probiotics alongside antibiotics was associated with roughly a 37-38% lower risk of antibiotic-associated diarrhea, without a statistically significant increase in adverse events. The size of the association varied by dose, species, and a population's baseline diarrhea risk, and the underlying evidence was graded as moderate quality. Those percentages describe relative risk. The absolute difference depends on the group’s starting risk.[1], [2], [3]

Limitations

The overall quality of the evidence was graded as moderate, and the pooled trials varied widely in probiotic strain, dose, and timing, which limits how precisely any single regimen can be recommended. The protective association was not seen in populations at low baseline diarrhea risk, so results may not apply to lower-risk clinical scenarios.[1], [2]

Both meta-analyses focused on adults; pooled adverse-event data showed no significant increase but do not establish safety for immunocompromised or critically ill people, and the findings are not medical advice.[2]

What does the evidence support?

Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.

Key findings, with their original qualifications and references
Finding and qualificationReferences
In pooled meta-analyses of randomized controlled trials in adults taking antibiotics, co-administration of probiotics was associated with an approximately 37-38% lower risk of antibiotic-associated diarrhea compared with placebo or no probiotic. Based on pooled randomized controlled trials in adults co-administering probiotics with antibiotics (variable strains and doses); GRADE quality of evidence rated moderate, and the effect was not seen in populations at low baseline diarrhea risk. The studied dose was Variable; high-dose subgroup showed greater protection than low-dose (RR 0.54).[1], [2]
In a meta-analysis of 36 randomized placebo-controlled trials in adults, probiotics taken alongside antibiotics were not associated with a statistically significant increase in adverse events compared with placebo (relative risk 1.00, 95% CI 0.87-1.14). Reflects pooled adverse-event reporting from randomized placebo-controlled trials of variable probiotic strains and doses in adults; does not establish safety for immunocompromised or critically ill people, who were not the focus of this pooled analysis. The studied dose was Variable; protective effect remained significant across probiotic dosage subgroups.[1], [2]
Pooled trial evidence indicates that the protective association between probiotics and antibiotic-associated diarrhea varies by dose and species, with one meta-analysis reporting greater risk reduction for a higher dose versus a lower dose of the same probiotic and benefit mainly from lactobacillus and bifidobacteria species. Subgroup findings from a single systematic review and meta-analysis (high dose vs low dose RR 0.54, 95% CI 0.38-0.76); optimal dose and duration remain undefined and no single regimen is established.[1], [2]
Diarrhea developed in 7 of 57 evaluable drink recipients (12%) and 19 of 56 placebo recipients (34%). The trial excluded severely ill and immunosuppressed patients. Results for this fermented drink do not identify a benefit for every probiotic capsule.[3]

What the pooled trials measured

Antibiotic-associated diarrhea is a common side effect of antibiotic treatment, and researchers have tested whether co-administering probiotics can reduce how often it occurs. Two 2021 meta-analyses pooled randomized controlled trials in adults: one synthesized 42 trials with 11,305 participants, and the other combined 36 randomized placebo-controlled trials with 9,312 participants. Both used the incidence of antibiotic-associated diarrhea as the primary outcome they measured.[1], [2]

Across both analyses, probiotics taken with antibiotics were associated with an approximately 37-38% lower risk of antibiotic-associated diarrhea relative to placebo or no probiotic (risk ratios near 0.62-0.63). These are pooled, population-level associations from trials using a range of probiotic strains and doses, not a result for any single product or regimen.[1], [2]

What did one trial find in absolute numbers?

One hospital trial tested a three-organism fermented drink twice daily during antibiotics and for one week afterward. Diarrhea developed in 7 of 57 evaluable drink recipients (12%) and 19 of 56 placebo recipients (34%). The trial excluded severely ill and immunosuppressed patients. Results for this fermented drink do not identify a benefit for every probiotic capsule.[3]

Dose, species, and baseline risk

The association was not uniform. In subgroup analyses from the 42-trial systematic review, a higher dose of the same probiotic was linked to greater protection than a lower dose, and the benefit came mainly from lactobacillus and bifidobacteria species. The same review reported no difference in studies where participants had a low baseline risk of diarrhea, with significant risk reduction concentrated in moderate- or high-risk settings.[1]

Both research teams noted that the optimal dose and duration of probiotics for this purpose remain undefined, so the subgroup signals describe where the effect appeared larger rather than establishing a specific recommended regimen.[1]

Adverse events in the pooled data

The 36-trial meta-analysis also pooled adverse event rates and found no statistically significant increase in adverse events among adults taking probiotics compared with placebo (relative risk 1.00, 95% CI 0.87-1.14). The authors described early co-administration during antibiotic therapy as having a positive effect on preventing antibiotic-associated diarrhea in the adult populations studied.[2]

How do relative and absolute benefits differ?

A 37% relative reduction is not 37 fewer cases in every 100 people. As an illustrative calculation, a baseline risk of 10 in 100 would become about 6.3 in 100 if a relative risk of 0.63 applied: about 3.7 fewer cases. That is an explanation of the statistic, not a prediction for a specific probiotic; the pooled benefit was not observed in low-baseline-risk populations.[1], [2]

The pooled adverse-event result also has a boundary. Adult antibiotic trials did not show an overall increase versus placebo, but this does not establish safety for immunocompromised or critically ill people. Neither the relative-risk estimate nor the dose subgroup determines one universally best strain, timing schedule, or duration for every antibiotic course.[1], [2]

References

  1. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.. BMJ open. 2021. Systematic review and meta-analysis View source →
  2. Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials.. Journal of clinical gastroenterology. 2021. Systematic review and meta-analysis View source →
  3. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ (Clinical research ed.). 2007. Randomized controlled trial View source →

Frequently asked questions

What does research show about probiotics taken with antibiotics?

In pooled randomized trials of adults, probiotics taken alongside antibiotics were associated with about a 37% to 38% lower risk of antibiotic-associated diarrhea. The effect varied by strain or species, dose, timing, and baseline risk, and the evidence does not establish one universal regimen.

Sources: Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.; Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Read the full FAQ and limitations →
Probiotics and Antibiotic Diarrhea — article outline
Original editorial diagram of this page’s topics; no product photograph or clinical finding is depicted.